Klotho is a longevity and neuroprotective hormone encoded by the KLOTHO gene, and heterozygosity for the KL-VS variant confers a protective effect against neurodegenerative disease.
Objective:
Test whether klotho concentrations in serum or cerebrospinal fluid (CSF) vary as a function of KLOTHO KL-VS genotype, determine whether circulating klotho concentrations from serum and CSF differ from one another, and evaluate whether klotho levels are associated with Alzheimer’s disease risk factors.
Methods:
Circulating klotho was measured in serum (n = 1,116) and CSF (n = 183) of cognitively intact participants (aged 62.4 ± 6.5 years; 69.5% female). KLOTHO KL-VS zygosity (non-carrier; heterozygote; homozygote) was also determined. Linear regression was used to test whether klotho hormone concentration varied as a function of KL-VS genotype, specimen source, and demographic and clinical characteristics.
Results:
Serum and CSF klotho were higher in KL-VS carriers than non-carriers. Klotho concentration was higher in CSF than in serum. Females had higher serum and CSF klotho, while younger age was associated with higher klotho in CSF.
Conclusion:
In a cohort enriched for risk for Alzheimer’s disease, heterozygotic and homozygotic carriers of the KL-VS allele, females, and younger individuals have higher circulating klotho. Fluid source, KL-VS genotype, age, and sex should be considered in analyses of circulating klotho on brain health.
Alzheimer’s Association (2021) 2021 Alzheimer’s disease facts and figures. Alzheimers Dement17, 327–406.
2.
ArkingDE, KrebsovaA, MacekMSr, MacekMJr, ArkingA, MianIS, FriedL, HamoshA, DeyS, McIntoshI, DietzHC (2002) Association of human aging with a functional variant of klotho. Proc Natl Acad Sci U S A99, 856–861.
3.
BelloyME, EgerSJ, Le GuenY, NapolioniV, DetersKD, YangHS, ScelsiMA, PorterT, JamesSN, WongA, SchottJM, SperlingRA, LawsSM, MorminoEC, HeZ, HanSS, AltmannA, GreiciusMD; A4 Study Team; Insight 46 Study Team; Australian Imaging Biomarkers and Lifestyle (AIBL) Study; Alzheimer’s Disease Neuroimaging Initiative (2021) KL *VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE *4 carriers. Neurobiol Aging101, 123–129.
4.
DriscollI, MaY, GallagherCL, JohnsonSC, AsthanaS, HermannBP, SagerMA, BlennowK, ZetterbergH, CarlssonCM, EngelmanCD, DubalDB, OkonkwoOC (2021) Age-related tau burden and cognitive deficits are attenuated in KLOTHO KL-VS heterozygotes. J Alzheimers Dis79, 1297–1305.Erratum J Alzheimers Dis. 2021;82(3):1369-1370.
NeitzelJ, FranzmeierN, RubinskiA, DichgansM, BrendelM, Alzheimer’s Disease Neuroimaging Initiative, MalikR, EwersM (2021) KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease. Nat Commun12, 3825.
7.
Mengel-FromJ, SoerensenM, NygaardM, McGueM, ChristensenK, ChristiansenL (2016) Genetic variants in KLOTHO associate with cognitive function in the oldest old group. J Gerontol Biol Sci Med Sci71, 1151–1159.
8.
BelloyME, NapolioniV, HanSS, Le GuenY, GreiciusMD, for the Alzheimer’s Disease Neuroimaging Initiative (2020) Association of klotho -VS heterozygosity with risk of Alzheimer disease in individuals who carry APOE4. JAMA Neurol77, 849–862.
9.
SedighiM, BaluchnejadmojaradT, FallahS, MoradiN, Afshin-MajddS, RoghaniM (2019) Klotho ameliorates cellular inflammation via suppression of cytokine release and upregulation of miR-29a in the PBMCs of diagnosed Alzheimer’s disease patients. J Mol Neurosci69, 157–165.
10.
WooHG, ChangY, RyuDR, SongTJ (2019) Plasma Klotho concentration is associated with the presence, burden and progression of cerebral small vessel disease in patients with acute ischaemic stroke. PLoS One14, e0220796.
11.
ZhouHJ, LiH, ShiMQ, MaoXN, LiuDL, ChangYR, GanYM, KuangX, DuJR (2017) Protective effect of klotho against ischemic brain injury is associated with inhibition of RIG-I/NF-kappaB Signaling. Front Pharmacol8, 950.
12.
YokoyamaJS, MarxG, BrownJA, BonhamLW, WangD, CoppolaG, SeeleyWW, RosenHJ, MillerBL, KramerJH, DubalDB (2017) Systemic klotho is associated with KLOTHO variation and predicts intrinsic cortical connectivity in healthy human aging. Brain Imaging Behav11, 391–400.
13.
BromboG, BonettiF, OrtolaniB, MorieriML, BosiC, PassaroA, VignaGB, BorgnaC, ArcidiconoMV, TisatoV, ZulianiG (2018) Lower plasma klotho concentrations are associated with vascular dementia but not late-onset Alzheimer’s disease. Gerontology64, 414–421.
14.
SembaRD, MoghekarAR, HuJ, SunK, TurnerR, FerrucciL, O’BrienR (2014) Klotho in the cerebrospinal fluid of adults with and without Alzheimer’s disease. Neurosci Lett558, 37–40.
15.
Emami AleaghaMS, SiroosB, AhmadiM, BaloodM, PalangiA, HaghighiAN, HarirchianMH (2015) Decreased concentration of Klotho in the cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis. J Neuroimmunol281, 5–8.
16.
ZimmermannM, KohlerL, KovarovaM, LercheS, SchulteC, WursterI, MachetanzG, DeuschleC, HauserAK, GasserT, BergD, SchleicherE, MaetzlerW, BrockmannK (2021) The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson s disease. Eur J Neurol28, 1557–1565.
LeonJ, MorenoAJ, GarayBI, ChalkleyRJ, BurlingameAL, WangD, DubalDB (2017) Peripheral elevation of a klotho fragment enhances brain function and resilience in young, aging, and α-synuclein transgenic mice. Cell Rep20, 1360–1371.
ZengC-Y, YangT-T, ZhouH-J, ZhaoY, KuangX, DuanW, DuJ-R (2019) Lentiviral vector–mediated overexpression of Klotho in the brain improves Alzheimer’s disease–like pathology and cognitive deficits in mice. Neurobiol Aging78, 18–28.
22.
SanzB, ArrietaH, Rezola-PardoC, Fernandez-AtutxaA, Garin-BalerdiJ, ArizagaN, Rodriguez-LarradA, IrazustaJ (2021) Low serum klotho concentration is associated with worse cognition, psychological components of frailty, dependence, and falls in nursing home residents. Sci Rep11, 9098.
23.
ShardellM, SembaRD, RosanoC, KalyaniRR, BandinelliS, ChiaCW, FerrucciL (2016) Plasma klotho and cognitive decline in older adults: Findings from the InCHIANTI study. J Gerontol A Biol Sci Med Sci71, 677–682.
24.
YokoyamaJS, SturmVE, BonhamLW, KleinE, ArfanakisK, YuL, CoppolaG, KramerJH, BennettDA, MillerBL, DubalDB (2015) Variation in longevity gene KLOTHO is associated with greater cortical volumes. Ann Clin Transl Neurol2, 215–230.
25.
de BruijnRF, IkramMA (2014) Cardiovascular risk factors and future risk of Alzheimer’s disease. BMC Med12, 130.
26.
RiedelBC, ThompsonPM, BrintonRD (2016) Age, APOE and sex: Triad of risk of Alzheimer’s disease. J Steroid Biochem Mol Biol160, 134–147.
27.
JohnsonSC, KoscikRL, JonaitisEM, ClarkLR, MuellerKD, BermanSE, BendlinBB, EngelmanCD, OkonkwoOC, HoganKJ, AsthanaS, CarlssonCM, HermannBP, SagerMA (2018) The Wisconsin Registry for Alzheimer’s Prevention: A review of findings and current directions. Alzheimers Dement (Amst)10, 130–142.
28.
SagerMA, HermannB, La RueA (2005) Middle-aged children of persons with Alzheimer’s disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer’s Prevention. J Geriatr Psychiatry Neurol18, 245–249.
29.
DarstBF, KoscikRL, RacineAM, OhJM, KrauseRA, CarlssonCM, ZetterbergH, BlennowK, ChristianBT, BendlinBB, OkonkwoOC, HoganKJ, HermannBP, SagerMA, AsthanaS, JohnsonSC, EngelmanCD (2017) Pathway-specific polygenic risk scores as predictors of amyloid-beta deposition and cognitive function in a sample at increased risk for Alzheimer’s disease. J Alzheimers Dis55, 473–484.
30.
YamazakiY, ImuraA, UrakawaI, ShimadaT, MurakamiJ, AonoY, HasegawaH, YamashitaT, NakataniK, SaitoY, OkamotoN, KurumataniN, NambaN, KitaokaT, OzonoK, SakaiT, HatayaH, IchikawaS, ImelEA, EconsMJ, NabeshimaY (2010) Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun398, 513–518.
YadlowskyS, HaywardRA, SussmanJB, McClellandRL, MinY-I, BasuS (2018) Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk. Ann Intern Med169, 20.
33.
InkerLA, SchmidCH, TighiouartH, EckfeldtJH, FeldmanHI, GreeneT, KusekJW, ManziJ, Van LenteF, ZhangYL, CoreshJ, LeveyAS (2012) Estimating glomerular filtration rate from serum creatinine and cystatin c. N Engl J Med367, 20–29.
34.
StoneNJ, RobinsonJG, LichtensteinAH, Bairey MerzCN, BlumCB, EckelRH, GoldbergAC, GordonD, LevyD, Lloyd-JonesDM, McBrideP, SchwartzJS, SheroST, SmithSC, WatsonK, WilsonPWF (2014) 2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol63, 2889–2934.
35.
ArkingDE, AtzmonG, ArkingA, BarzilaiN, DietzHC (2005) Association between a functional variant of the klotho gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ Res96, 412–418.
36.
InvidiaL, SalvioliS, AltiliaS, PieriniM, PanourgiaMP, MontiD, De RangoF, PassarinoG, FranceschiC (2010) The frequency of Klotho KL-VS polymorphism in a large Italian population, from young subjects to centenarians, suggests the presence of specific time windows for its effect. Biogerontology11, 67–73.
37.
Tucker ZhouTB, KingGD, ChenC, AbrahamCR (2013) Biochemical and functional characterization of the klotho-VS polymorphism implicated in aging and disease risk. J Biol Chem288, 36302–36311.
38.
da Paz OliveiraG, EliasRM, Peres FernandesGB, MoysesR, TufikS, BichuettiDB, CoelhoFMS (2021) Decreased concentration of klotho and increased concentration of FGF23 in the cerebrospinal fluid of patients with narcolepsy. Sleep Med78, 57–62.
39.
KunertSK, HartmannH, HaffnerD, Leifheit-NestlerM (2017) Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children. J Bone Min Metab35, 215–226.
40.
HoyerC, SartoriusA, AksaySS, BumbJM, JankeC, ThielM, HaffnerD, Leifheit-NestlerM, KranasterL (2018) Electroconvulsive therapy enhances the anti-ageing hormone Klotho in the cerebrospinal fluid of geriatric patients with major depression. Eur Neuropsychopharmacol28, 428–435.
41.
KunduP, ZimmermanB, QuinnJF, KayeJ, MattekN, WestawaySK, RaberJ (2022) Serum levels of α-klotho are correlated with cerebrospinal fluid levels and predict measures of cognitive function. J Alzheimers Dis86, 1471–1481.
42.
SembaRD, CappolaAR, SunK, BandinelliS, DalalM, CrastoC, GuralnikJM, FerrucciL (2011) Plasma klotho and mortality risk in older community-dwelling adults. J Gerontol A Biol Sci Med Sci66A, 794–800.
43.
Espuch-OliverA, Vazquez-LorenteH, Jurado-FasoliL, de Haro-MuñozT, Díaz-AlberolaI, López-VelezMDS, de Haro-RomeroT, CastilloMJ, Amaro-GaheteFJ (2022) References values of soluble α-klotho serum levels using an enzyme-linked immunosorbent assay in healthy adults aged 18-85 years. J Clin Med11, 2415.
44.
PedersenL, PedersenSM, BrasenCL, RasmussenLM (2013) Soluble serum Klotho levels in healthy subjects. Comparison of two different immunoassays. Clin Biochem46, 1079–1083.
45.
DavisEJ, BroestlL, Abdulai-SaikuS, WordenK, BonhamLW, Miñones-MoyanoE, MorenoAJ, WangD, ChangK, WilliamsG, GarayBI, LobachI, DevidzeN, KimD, Anderson-BergmanC, YuG-Q, WhiteCC, HarrisJA, MillerBL, BennettDA, ArnoldAP, JagerPLD, PalopJJ, PanningB, YokoyamaJS, MuckeL, DubalDB (2020) A second X chromosome contributes to resilience in a mouse model of Alzheimer’s disease. Sci Transl Med12, eaaz5677.
46.
PorterT, BurnhamSC, MilicicL, SavageG, MaruffP, LimYY, AmesD, MastersCL, MartinsRN, Rainey-SmithS, RoweCC, SalvadoO, GrothD, VerdileG, VillemagneVL, LawsSM (2019) Klotho allele status is not associated with Aβ and APOE ɛ4–related cognitive decline in preclinical Alzheimer’s disease. Neurobiol Aging{76, 162–165.
